Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Pole striding exercise and vitamin E for management of peripheral vascular disease
Collins EG, Edwin Langbein W, Orebaugh C, Bammert C, Hanson K, Reda D, Edwards LC, Littooy FN
Medicine and Science in Sports and Exercise 2003 Mar;35(3):384-393
clinical trial
6/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

PURPOSE: The purpose of this investigation was to evaluate the efficacy of pole striding exercise (a form of walking that uses muscles of the upper and lower body in a continuous movement similar to cross-country skiing) and vitamin E (alpha-tocopherol) to improve walking ability and perceived quality of life (QOL) of patients with claudication pain secondary to peripheral arterial disease (PAD). METHODS: Fifty-two subjects were randomized into four groups: pole striding with vitamin E (N = 13), pole striding with placebo (N = 14), vitamin E without exercise (N = 13), and placebo without exercise (N = 12). The dose of vitamin E was 400 IU daily. Only the pole striding with vitamin E and pole striding with placebo groups received pole striding instruction and training. Assignment to vitamin E or placebo was double blind. Subjects trained three times weekly for 30 to 45 min (rest time excluded). Individuals in vitamin E and placebo groups came to the laboratory biweekly for ankle blood-pressure measurements. RESULTS: Results of this randomized clinical trial provide strong evidence that pole striding significantly (p < 0.001) improved exercise tolerance on the constant work-rate and incremental treadmill tests. Ratings of perceived claudication pain were significantly less after the pole striding training program (p = 0.02). In contrast, vitamin E did not have a statistically significant effect on the subjects' ratings of perceived leg pain (p = 0.35) or treadmill walking duration (p = 0.36). Perceived distance and walking speed (Walking Impairment Questionnaire) and perceived physical function (Rand Short Form-36) improved in the pole striding trained group only (p < 0.001, 0.022 and 0.003, respectively). CONCLUSION: Pole striding effectively improved the exercise tolerance and perceived QOL of patients with PAD. Little additional benefit to exercise capacity was realized from vitamin E supplementation.

Full text (sometimes free) may be available at these link(s):      help